Loading patent…
AssigneesAlena Alexandrovna Ivachtchenko, Alla Chem, LLC
InventorsAlexandre Vasilievich Ivachtchenko, Andrey Alexandrovich Ivashchenko, Nikolay Filippovich Savchuk
Estimating the term…
The present invention relates to a novel combination drug in a solid oral dosage form comprising, as one of the three active ingredients, elsulfavirine sodium that may be suitable for medical use when treating viral infections including HIV and HBV. An antiviral combination drug in a solid oral dosage form comprising, as one of the three active ingredients, a therapeutically effective amount of elsulfavirine sodium of formula 1a in a crystalline or polycrystalline form optionally in combination with auxiliary agents:
A combination drug in a solid dosage form for the treatment of viral infections comprising, as one of the three active ingredients, a therapeutically effective amount of elsulfavirine sodium of formula 1a in a crystalline or polycrystalline form optionally in combination with auxiliary agents:
A method for producing a combination drug formulated in tablets by mixing therapeutically effective amounts of elsulfavirine sodium of formula 1a, an NRTI precursor of formulas 2a-2j or a pharmaceutically acceptable salt thereof, and an NtRTI precursor of formula 3 or formulas 4a-4m or a pharmaceutically acceptable salt thereof with auxiliary agents followed by compression.
Dependencies are inferred from the claim text.